Acute lymphoblastic leukaemia: open trials in Belgium

16 open trials have a site in Belgium. Registry data; only the trial team decides who can take part.

NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Universitair Ziekenhuis Gent, Gent
Registry updated 2026-10-30
NCT07476729
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
Trial Treatment · Phase 3 · Charite University, Berlin, Germany
Ghent university hospital, Ghent
Registry updated 2026-10-26
NCT05327894
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Trial Treatment · Phase 3 · Princess Maxima Center for Pediatric Oncology
Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola, Brussels · Antwerp University Hospital, Edegem · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven · CHC MontLégia, Liège · Centre Hospitalier Regional de la Citadelle, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-10-19
NCT07648264
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Trial Treatment · Phase 3 · CSL Behring
Universitair Ziekenhuis Antwerpen (Uza), Edegem · UZ Gent, Ghent · CHU de Liège, Liège · AZ Delta, Roeselare
Registry updated 2026-10-14
NCT03934372
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Trial Treatment · Phase 1/2 · Incyte Biosciences International Sàrl
Ghent university hospital, Ghent
Registry updated 2026-10-09
NCT05748171
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
Trial Treatment · Phase 2 · Pfizer
Universiteit Gent, Gent · UZ Leuven, Leuven · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-09-24
NCT01949129
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Trial Treatment · Phase 2/3 · St. Anna Kinderkrebsforschung
Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola, Brussels · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven · Centre Hospitalier Universitaire de Liège, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-09-04
NCT04307576
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Trial Treatment · Phase 3 · Mats Heyman
Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola, Brussels · Antwerp University Hospital, Edegem · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven · CHC MontLégia, Liège · Centre Hospitalier Regional de la Citadelle, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-08-12
2023-504694-20-00
Inotuzumab ozogamicin for Acute Lymphoblastic Leukemia
Trial Treatment · Phase 1/2 · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Universitair Ziekenhuis Gent, Gent
Registry updated 2026-06-04
NCT04988555
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Trial Treatment · Phase 1/2 · Sumitomo Pharma America, Inc.
ZNA Cadix, Antwerp · UZ Ghent, Ghent · University Hospitals Leuven, Leuven · AZ Delta, Roeselare
Registry updated 2026-03-24
NCT03590171
International Study for Treatment of High Risk Childhood Relapsed ALL 2010
Trial Treatment · Phase 2 · Charite University, Berlin, Germany
Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola, Brussels · Antwerp University Hospital, Edegem · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven · CHC MontLégia, Liège · Centre Hospitalier Regional de la Citadelle, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-03-17
NCT05658640
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology
UZ Gent, Gent
Registry updated 2025-09-16
NCT05745714
HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology
Universitair Ziekenhuis Gent, Gent
Registry updated 2025-09-16
NCT05751044
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology
Universitair Ziekenhuis Gent, Gent
Registry updated 2025-09-16
NCT02617004
GRAALL2014
Trial Treatment · Phase 2 · Assistance Publique Hopitaux De Paris
Institut Jules Bordet, Anderlecht · Grand Hopital de Charleroi, Charleroi · Chu Helora, La Louvière · Centre Hospitalier Universitaire de Liège, Liège · CHU De Charleroi Hopital Andre Vesale, Montigny-Le-Tilleul · Universite Catholique de Louvain, Sint-Lambrechts-Woluwe · Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur, Yvoir
Registry updated 2025-01-17
NCT03852407
Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning
Trial Treatment · Phase 2 · University of Liege
Institut Jules Bordet, Anderlecht · Ziekenhuis Aan De Stroom, Antwerp · Az St-Jan Brugge-Oostende A.V., Brugge · Universiteit Gent, Gent · Vrije Universiteit Brussel, Jette · UZ Leuven, Leuven · Algemeen Ziekenhuis Delta, Roeselare · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe · Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur, Yvoir
Registry updated 2022-10-12

All Acute lymphoblastic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error